6 ADHD Clinical Trials in Indianapolis, IN (2026)

Q: How do I join a clinical trial in Indianapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you.

Recruiting ADHD Studies in Indianapolis

NCT02660645Recruiting

Blue Light Cystoscopy With Cysview® Registry

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices....

Indianapolis, IN4,400 participantsPhotocure

View Study Details

NCT05614739Recruiting

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-435 by itself or when it is combined with other standard medicines that treat cancer. LOXO-435...

Indianapolis, INPHASE1535 participantsEli Lilly and Company

View Study Details

NCT05982561Recruiting

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

BCDx is a urine-based multi-omic assay for early cancer recurrence detection in patients with a history of bladder cancer. This prospective, blinded study evaluates its efficacy in detecting recurrent...

Indianapolis, IN500 participantsEarly is Good Inc.

View Study Details

NCT05200923Recruiting

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

To collect physiological signals at several timepoints during the therapy evaluation period....

Indianapolis, INNA300 participantsMedtronicNeuro

View Study Details

NCT07309445Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer...

Indianapolis, IN150 participantsJanssen Research & Development, LLC

View Study Details

NCT06809140Recruiting

Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer

Patients with MIBC will receive 3 cycles (C1-C3) of induction enfortumab vedotin plus pembrolizumab followed by restaging including MRI of the bladder, urine cytology, and cystoscopy with TURBT of any...

Indianapolis, INPHASE247 participantsMatthew Galsky

View Study Details

About ADHD Clinical Trials in Indianapolis

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 6 adhd clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 5,932 participants. Research is being sponsored by Photocure, Eli Lilly and Company, Early is Good Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Indianapolis — FAQ

Are there adhd clinical trials in Indianapolis?

Yes, there are 6 adhd clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What adhd treatments are being tested?

The 6 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated July 18, 2026 from ClinicalTrials.gov